BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 27974681)

  • 1. Loss of expression of the recycling receptor, FcRn, promotes tumor cell growth by increasing albumin consumption.
    Swiercz R; Mo M; Khare P; Schneider Z; Ober RJ; Ward ES
    Oncotarget; 2017 Jan; 8(2):3528-3541. PubMed ID: 27974681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct demonstration of a neonatal Fc receptor (FcRn)-driven endosomal sorting pathway for cellular recycling of albumin.
    Schmidt EGW; Hvam ML; Antunes F; Cameron J; Viuff D; Andersen B; Kristensen NN; Howard KA
    J Biol Chem; 2017 Aug; 292(32):13312-13322. PubMed ID: 28637874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of a double transgenic humanized neonatal Fc receptor (FcRn)/albumin mouse to study the pharmacokinetics of albumin-linked drugs.
    Viuff D; Antunes F; Evans L; Cameron J; Dyrnesli H; Thue Ravn B; Stougaard M; Thiam K; Andersen B; Kjærulff S; Howard KA
    J Control Release; 2016 Feb; 223():22-30. PubMed ID: 26699424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal Fc Receptor Binding Tolerance toward the Covalent Conjugation of Payloads to Cysteine 34 of Human Albumin Variants.
    Petersen SS; Kläning E; Ebbesen MF; Andersen B; Cameron J; Sørensen ES; Howard KA
    Mol Pharm; 2016 Feb; 13(2):677-82. PubMed ID: 26654692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Albumin binding to FcRn: distinct from the FcRn-IgG interaction.
    Chaudhury C; Brooks CL; Carter DC; Robinson JM; Anderson CL
    Biochemistry; 2006 Apr; 45(15):4983-90. PubMed ID: 16605266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic FcRn regulates albumin homeostasis and susceptibility to liver injury.
    Pyzik M; Rath T; Kuo TT; Win S; Baker K; Hubbard JJ; Grenha R; Gandhi A; Krämer TD; Mezo AR; Taylor ZS; McDonnell K; Nienaber V; Andersen JT; Mizoguchi A; Blumberg L; Purohit S; Jones SD; Christianson G; Lencer WI; Sandlie I; Kaplowitz N; Roopenian DC; Blumberg RS
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2862-E2871. PubMed ID: 28330995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction with both domain I and III of albumin is required for optimal pH-dependent binding to the neonatal Fc receptor (FcRn).
    Sand KM; Bern M; Nilsen J; Dalhus B; Gunnarsen KS; Cameron J; Grevys A; Bunting K; Sandlie I; Andersen JT
    J Biol Chem; 2014 Dec; 289(50):34583-94. PubMed ID: 25344603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half-life extension of efficiently produced DARPin serum albumin fusions as a function of FcRn affinity and recycling.
    Merten H; Brandl F; Zimmermann M; Schaefer JV; Irpinio L; Sand KMK; Nilsen J; Andersen JT; Zangemeister-Wittke U; Plückthun A
    Eur J Pharm Biopharm; 2021 Oct; 167():104-113. PubMed ID: 34303832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy gene
    Uchida Y; Torisu K; Ueki K; Tsuruya K; Nakano T; Kitazono T
    Am J Physiol Renal Physiol; 2021 Nov; 321(5):F572-F586. PubMed ID: 34541900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Half-life-extended recombinant coagulation factor IX-albumin fusion protein is recycled via the FcRn-mediated pathway.
    Chia J; Louber J; Glauser I; Taylor S; Bass GT; Dower SK; Gleeson PA; Verhagen AM
    J Biol Chem; 2018 Apr; 293(17):6363-6373. PubMed ID: 29523681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altering Antibody-Drug Conjugate Binding to the Neonatal Fc Receptor Impacts Efficacy and Tolerability.
    Hamblett KJ; Le T; Rock BM; Rock DA; Siu S; Huard JN; Conner KP; Milburn RR; O'Neill JW; Tometsko ME; Fanslow WC
    Mol Pharm; 2016 Jul; 13(7):2387-96. PubMed ID: 27248573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal FcRn reclaims albumin but facilitates elimination of IgG.
    Sarav M; Wang Y; Hack BK; Chang A; Jensen M; Bao L; Quigg RJ
    J Am Soc Nephrol; 2009 Sep; 20(9):1941-52. PubMed ID: 19661163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular recycling-driven in vivo half-life extension using recombinant albumin fusions tuned for neonatal Fc receptor (FcRn) engagement.
    Larsen MT; Rawsthorne H; Schelde KK; Dagnæs-Hansen F; Cameron J; Howard KA
    J Control Release; 2018 Oct; 287():132-141. PubMed ID: 30016735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Humanized Mouse Model to Study Human Albumin and Albumin Conjugates Pharmacokinetics.
    Low BE; Wiles MV
    Methods Mol Biol; 2016; 1438():115-22. PubMed ID: 27150087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in vitro and in vivo.
    Dylewski J; Dobrinskikh E; Lewis L; Tonsawan P; Miyazaki M; Jat PS; Blaine J
    PLoS One; 2019; 14(2):e0209732. PubMed ID: 30811433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neonatal Fc receptor induces intravenous immunoglobulin growth suppression in Langerhans cell histiocytosis.
    Nabeshima Y; Kataoka TR; Ueshima C; Saito N; Hirata M; Takeuchi Y; Takei Y; Moriyoshi K; Ono K; Haga H
    Pathol Int; 2021 Mar; 71(3):191-198. PubMed ID: 33497038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand valency affects transcytosis, recycling and intracellular trafficking mediated by the neonatal Fc receptor.
    Tesar DB; Tiangco NE; Bjorkman PJ
    Traffic; 2006 Sep; 7(9):1127-42. PubMed ID: 17004319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS-enhanced macropinocytosis and reduced FcRn-mediated recycling sensitize pancreatic cancer to albumin-conjugated drugs.
    Liu H; Sun M; Liu Z; Kong C; Kong W; Ye J; Gong J; Huang DCS; Qian F
    J Control Release; 2019 Feb; 296():40-53. PubMed ID: 30653981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of FcRn binding to intestinal uptake of IgG in suckling rat pups and human FcRn-transgenic mice.
    Kliwinski C; Cooper PR; Perkinson R; Mabus JR; Tam SH; Wilkinson TM; Giles-Komar J; Scallon B; Powers GD; Hornby PJ
    Am J Physiol Gastrointest Liver Physiol; 2013 Feb; 304(3):G262-70. PubMed ID: 23220220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An engineered affibody molecule with pH-dependent binding to FcRn mediates extended circulatory half-life of a fusion protein.
    Seijsing J; Lindborg M; Höidén-Guthenberg I; Bönisch H; Guneriusson E; Frejd FY; Abrahmsén L; Ekblad C; Löfblom J; Uhlén M; Gräslund T
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17110-5. PubMed ID: 25406323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.